Midgard Science

Sterling Pharma Solutions

Cork, Ireland sterlingpharmasolutions.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Sterling Pharma Solutions is a small molecule partnership development and manufacturing organisation serving pharmaceutical and biotech companies. It provides API development and manufacturing, ADC development and manufacturing, peptide services, and related chemistry and analytical support across facilities in the UK, Ireland, and the US.

Services

  • API development and manufacturing

    Supports API projects from route scouting and design through process optimisation, clinical supply, and commercial cGMP manufacturing.

  • ADC development and manufacturing

    Supports ADC projects from discovery and development through preclinical and clinical cGMP manufacture, including bioconjugation.

  • Peptide manufacturing

    Provides analysis, purification, and manufacturing of novel, long chain peptides.

  • Drug discovery

    Offers drug discovery services from initial screening to lead optimisation, combining analytical and medicinal chemistry expertise.

  • Early scale up

    Supports route scouting, evaluation, selection, and process development for preclinical and early clinical studies.

  • Analytical services

    Provides analytical development and analytical support for API development and manufacturing.

  • Full Time Equivalent (FTE)

    Provides dedicated scientists who support a project exclusively over an allocated period of time.

  • Hazard evaluation

    Assesses hazardous chemistry risks during process scale-up and manufacturing and supports mitigation strategies.

14 more services
  • Chiral chemistry
  • Continuous | Flow
  • Biocatalysis
  • Solid state chemistry
  • Milling/micronisation
  • Large-scale chromatography
  • Radiolabelling
  • Technology transfer
  • Milling and micronisation
  • Continuous flow chemistry
  • Hazardous chemistry
  • Controlled substances work
  • Early drug discovery chemistry
  • Preclinical and early phase clinical supply

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • ADC
  • Peptide
  • Analytical development
  • LC-MS/MS
  • NMR
Capacity
  • Grammes to tonnes
  • 175m3 reactor capacity
  • 3 API manufacturing buildings
  • 6,500m² facility
  • 42 acre facility
  • 111 acre site
4 more
  • 27,000 sq/ft facility
  • 1,442 sq/ft facility
  • 200 litre batches
  • Up to 100g
Scales
Gram
Data supplied
NMR

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: cGMP (API manufacturing and clinical supply)

Industries served

  • Pharmaceutical
  • Biotech

Company

Type
CDMO
Founded
1994
Team
Over 1,300 employees

Locations

Office
1001 Sheldon Drive Suite 101 Cary NC 27513 United States
Sites
  • Cramlington, UK
  • Deeside, UK
  • Newcastle Biosphere, UK
  • North Carolina, US
  • Wisconsin, US
  • Newcastle, UK
Serves
UK, US, EU, Japan, Rest of world

Public records

Parent company
STERLING PHARMA SOLUTIONS LIMITED · GB GLEIF
FDA drug establishment registration
3002806719 · ANALYSIS; API MANUFACTURE source

Similar labs